Technical Analysis for APGE - Apogee Therapeutics, Inc.

Grade Last Price % Change Price Change
C 47.43 -0.19% -0.09
APGE closed down 3.43 percent on Thursday, July 18, 2024, on approximately normal volume.
4 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
Spinning Top Other -0.19%
Upper Bollinger Band Walk Strength -0.19%
Wide Bands Range Expansion -0.19%
Overbought Stochastic Strength -0.19%
Upper Bollinger Band Walk Strength -3.62%
Multiple of Ten Bearish Other -3.62%
Wide Bands Range Expansion -3.62%
Overbought Stochastic Strength -3.62%
Upper Bollinger Band Touch Strength -3.62%
Gapped Down Weakness -3.62%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 3 hours ago
10 DMA Support about 5 hours ago
Fell Below Previous Day's Low about 5 hours ago
60 Minute Opening Range Breakdown about 5 hours ago
Down 3% about 5 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs include APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. The company was founded in 2022 and is based in Waltham, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Immunology Antibodies Monoclonal Antibodies Occupational Safety And Health Chronic Obstructive Pulmonary Disease Atopic Dermatitis Dermatitis Inflammatory Monoclonal Antibody Therapy Copd

Is APGE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 72.29
52 Week Low 14.22
Average Volume 499,552
200-Day Moving Average 37.74
50-Day Moving Average 44.91
20-Day Moving Average 41.72
10-Day Moving Average 45.01
Average True Range 2.74
RSI (14) 60.47
ADX 26.4
+DI 33.68
-DI 21.05
Chandelier Exit (Long, 3 ATRs) 44.17
Chandelier Exit (Short, 3 ATRs) 44.49
Upper Bollinger Bands 50.78
Lower Bollinger Band 32.66
Percent B (%b) 0.82
BandWidth 43.42
MACD Line 1.41
MACD Signal Line 0.02
MACD Histogram 1.3978
Fundamentals Value
Market Cap 2.28 Billion
Num Shares 48 Million
EPS
Price-to-Sales 0.00
Price-to-Book 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 53.40
Resistance 3 (R3) 53.55 51.75 52.42
Resistance 2 (R2) 51.75 50.25 51.67 52.09
Resistance 1 (R1) 49.63 49.32 48.73 49.48 51.77
Pivot Point 47.83 47.83 47.38 47.75 47.83
Support 1 (S1) 45.71 46.33 44.81 45.56 43.27
Support 2 (S2) 43.91 45.40 43.83 42.95
Support 3 (S3) 41.79 43.91 42.62
Support 4 (S4) 41.64